Skip to main content
. 2022 Feb 24;9:820260. doi: 10.3389/fcvm.2022.820260

Table 2.

Data analysis using the crude and adjusted Cox regression models considering mortality as a single outcome.

Variable Level variable Death (n = 73, 12.5%) Crude model Adjusted model
HR (95% CI) p HR (95% CI) p
Age (mean ± S.D) 75.8 ± 14.9 1.04 (1.02, 1.06) 0.001 1.02 (1.01, 1.05) 0.034
Sex Female (n, %) 29(10.5) Baseline 0.095
Male (n, %) 44 (14.4) 1.49 (0.93, 2.38)
ICU ICU 40 (51.9) Baseline 0.001 Baseline 0.117
3.69 (2.18, 6.25) 1.89 (0.85, 4.20)
Atorvastatin Yes (n, %) 17 (10.4) Baseline 0.040 Baseline 0.114
0.56 (0.32, 0.97) 0.51 (0.22, 1.17)
Sign and symptoms
Fever Yes (n, %) 25 (8.6) Baseline 0.001 Baseline 0.467
0.44 (0.27, 0.72) 1.30 (0.64, 2.63)
Cough Yes (n, %) 22 (10.3) Baseline 0.027 Baseline 0.711
0.56 (0.34, 0.93) 0.87 (0.43, 1.76)
ARDS Yes (n, %) 34 (16.7) Baseline 0.367
1.23 (0.77, 1.96)
Consciousness Yes (n, %) 10 (30.3) Baseline 0.103
1.75 (0.89, 3.43)
Comorbidities
Diabetes Yes (n, %) 15 (18.5) Baseline 0.133
1.54 (0.87, 2.73)
Cardiovascular diseases Yes (n, %) 26 (17.8) Baseline 0.011 Baseline 0y.023
1.86 (1.15, 3.01) 2.37 (1.13, 4.99)
Asthma Yes (n, %) 12 (22.6) Baseline 0.109
1.66 (0.89, 3.09)
Hypertension Yes (n, %) 22 (14.1) Baseline 0.793
1.06 (0.54, 1.76)
Oxygen therapy status Yes (n, %) 35 (29.9) Baseline 0.001 Baseline 0.776
2.89 (1.59, 5.24) 1.11 (0.53, 2.32)
Other
Intubation Yes (n, %) 22 (91.6) Baseline 0.001 Baseline 0.056
5.25 (2.95, 9.34) 2.16 (0.98, 4.80)
pO2 <93% 55 (19.2) Baseline 0.002 Baseline 0.255
>93% 16 (5.7) 0.41 (0.23, 0.73) 0.58 (0.22, 1.49)
Number of breaths 14–18 4 (11.4) Baseline 0.434
18–22 13 (10.6) 0.63 (0.20, 1.97)
>22 12 (42.8) 1.92 (0.60, 6.10) 0.266
CT scan Yes (n, %) 22 (13.7) Baseline 0.874 - –
0.95 (0.54, 1.68)
Opium use Yes (n, %) 8 (19.5) Baseline 0.080
1.93 (0.92, 4.04)
SPO2 (mean ± S.D) 85.4 ± 10.2 0.94 (0.92, 0.96) 0.001 0.96 (0.92, 0.99) 0.035
Body temperature (mean ± S.D) 36.8 ± 0.6 0.69 (0.47, 1.01) 0.060
The time from the onset of symptoms to hospitalization (mean ± S.D) 4.4 ± 2.3 0.94 (0.84, 1.04) 0.253
Laboratory measures
WBC (mean ± S.D) 9.8 ± 4.3 1.02 (1.01, 1.04) 0.012 1.04 (0.93, 1.16) 0.459
HB (mean ± S.D) 12.2 ± 1.8 0.90 (0.79, 1.03) 0.145
PLT (mean ± S.D) 194.3 ± 87.9 0.99 (0.99, 1.00) 0.399
Neut (mean ± S.D) 78.0 ± 14.9 1.01 (0.99, 1.03) 0.191
Lymph (mean ± S.D) 15.3 ± 11.8 0.97 (0.95, 1.00) 0.056
RDW (mean ± S.D) 15.0 ± 2.2 1.17 (1.06, 1.29) 0.001 0.91 (0.76, 1.09) 0.318
MPV (mean ± S.D) 10.0 ± 1.0 0.99 (0.79, 1.24) 0.941
BUN (mean ± S.D) 23.8 ± 16.7 1.02 (1.01, 1.04) 0.001 1.01 (0.92, 1.04) 0.198
Cr (mean ± S.D) 1.5 ± 1.8 1.13 (1.01, 1.26) 0.025 1.18 (1.01, 1.39) 0.044
CRP (mean ± S.D) 1.1 ± 0.6 1.03 (0.75, 1.41) 0.835

P < 0.05 was considered significant.